GORE® CARDIOFORM ASD occluder thrombus in a patient of rheumatoid arthritis occurred three days after deployment

A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully d...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of cardiology congenital heart disease Vol. 21; p. 100600
Main Authors Nakagawa, Naomi, Shigemitsu, Yusuke, Okamoto, Kengo
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier B.V 01.09.2025
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis.
AbstractList AbstractA 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis.
A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis.
A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis.A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial septal defect (ASD). After the administration of aspirin and intravenous heparin, a 32-mm of GORE® CARDIOFORM ASD occluder was successfully deployed. On postprocedural day 3, transthoracic echocardiography showed mobile echogenic mass of 9 mm on the right side of the device. Intravenous heparin 10 IU/kg/hr was administrated continuously, and clopidogrel was added. On the following day, the mobile mass was not visible. Even though the occurrence rate of device thrombus is not high, device thrombosis can become a major complication of device closure of ASD because it may cause systemic and/or pulmonary embolism. Administration of dual antiplatelet therapy or other anticoagulant therapy should be considered if the patients have a higher risk of thrombosis.
ArticleNumber 100600
Author Shigemitsu, Yusuke
Nakagawa, Naomi
Okamoto, Kengo
Author_xml – sequence: 1
  givenname: Naomi
  orcidid: 0000-0002-6357-7582
  surname: Nakagawa
  fullname: Nakagawa, Naomi
  email: polonekogorogoro@dream.com
– sequence: 2
  givenname: Yusuke
  surname: Shigemitsu
  fullname: Shigemitsu, Yusuke
– sequence: 3
  givenname: Kengo
  surname: Okamoto
  fullname: Okamoto, Kengo
BackLink https://www.ncbi.nlm.nih.gov/pubmed/40698378$$D View this record in MEDLINE/PubMed
BookMark eNqVks1u3CAUha0qVZOmeYOqYtnNpIANY6Sq1Wjy05FSjTTJHmG4ZHBtMwE70rxUHqJPVlynUbKoqq5AcM534d7zNjvofAdZ9p7gU4IJ_1SfulrrrTmlmLJ0hDnGr7IjyjmfcV6yg2f7w-wkxhpjTMskZORNdlhgLsp8Xh5ld5frzfnPB7RcbM5W64v15jtaXJ8hr3UzGAio3wbfVkNErkMK7VTvoOuRtyhsYWhV751BKiSV610cbUMIYEYbADJqH5GyfeIY2DV-3ybzu-y1VU2Ek8f1OLu5OL9ZfptdrS9Xy8XVTLNS9DOllBGcWsP4nFGtS1twVQIlRGuBCcXVnKrCCFOAVZXNBbWckIqknS1pkR9nqwlrvKrlLrhWhb30ysnfBz7cyvRupxuQXAMzzAph1LwoTVUxxgrCheEcFDMisb5OrN1QtWB0-kVQzQvoy5vObeWtv5eEpp6TokyEj4-E4O8GiL1sXdTQNKoDP0SZ05wWIk1nlH54Xuypyp-ZJUExCXTwMQawTxKC5ZgOWcspHXJMh5zSkWxfJhukpt87CDLqNEwNxgXQfWqL-1-AblzntGp-wB5i7YfQpYFKIiOVWF6PARzzR1nKXs7HNn7-O-Df9X8Bv93uJg
Cites_doi 10.1007/s10067-014-2492-7
10.1136/annrheumdis-2013-203380
10.1002/ccd.31002
10.1002/ccd.30067
10.1016/0090-1229(92)90008-C
10.1136/annrheumdis-2020-218419
10.1016/j.jacc.2003.10.030
10.1002/ccd.24875
10.1002/ccd.28728
ContentType Journal Article
Copyright 2025 The Authors
The Authors
2025 The Authors.
2025 The Authors 2025
Copyright_xml – notice: 2025 The Authors
– notice: The Authors
– notice: 2025 The Authors.
– notice: 2025 The Authors 2025
DBID 6I.
AAFTH
AAYXX
CITATION
NPM
7X8
5PM
DOA
DOI 10.1016/j.ijcchd.2025.100600
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic


PubMed
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
EISSN 2666-6685
EndPage 100600
ExternalDocumentID oai_doaj_org_article_6ce5d5f99da748dbb5554169d66ea5d9
PMC12281148
40698378
10_1016_j_ijcchd_2025_100600
S2666668525000369
1_s2_0_S2666668525000369
Genre Journal Article
Case Reports
GroupedDBID .1-
.FO
0R~
1P~
AAEDW
AALRI
AAXUO
AAYWO
ACVFH
ADCNI
ADVLN
AEUPX
AFJKZ
AFPUW
AFRHN
AIGII
AITUG
AJUYK
AKBMS
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
EBS
FDB
GROUPED_DOAJ
M~E
OK1
ROL
RPM
Z5R
AFCTW
6I.
AAFTH
AAYXX
CITATION
NPM
7X8
5PM
ID FETCH-LOGICAL-c589t-aaad962fd56752cc8f46a8e211cc90120b72a4d9d4efabf392f611b1f39f8243
IEDL.DBID DOA
ISSN 2666-6685
IngestDate Wed Aug 27 00:48:05 EDT 2025
Thu Aug 21 18:25:38 EDT 2025
Thu Jul 24 01:49:10 EDT 2025
Sat Jul 26 01:47:05 EDT 2025
Wed Jul 16 16:47:54 EDT 2025
Sat Aug 16 17:01:18 EDT 2025
Fri Aug 08 06:00:36 EDT 2025
Tue Aug 26 16:32:07 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords Thrombus formation
Atrial septal defect
GORE cardioform ASD occluder
Congenital heart disease
Rheumatoid arthritis
Language English
License This is an open access article under the CC BY-NC license.
2025 The Authors.
This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c589t-aaad962fd56752cc8f46a8e211cc90120b72a4d9d4efabf392f611b1f39f8243
Notes ObjectType-Case Study-2
SourceType-Scholarly Journals-1
ObjectType-Feature-4
content type line 23
ObjectType-Report-1
ObjectType-Article-3
ORCID 0000-0002-6357-7582
OpenAccessLink https://doaj.org/article/6ce5d5f99da748dbb5554169d66ea5d9
PMID 40698378
PQID 3232490058
PQPubID 23479
PageCount 1
ParticipantIDs doaj_primary_oai_doaj_org_article_6ce5d5f99da748dbb5554169d66ea5d9
pubmedcentral_primary_oai_pubmedcentral_nih_gov_12281148
proquest_miscellaneous_3232490058
pubmed_primary_40698378
crossref_primary_10_1016_j_ijcchd_2025_100600
elsevier_sciencedirect_doi_10_1016_j_ijcchd_2025_100600
elsevier_clinicalkeyesjournals_1_s2_0_S2666668525000369
elsevier_clinicalkey_doi_10_1016_j_ijcchd_2025_100600
PublicationCentury 2000
PublicationDate 2025-09-01
PublicationDateYYYYMMDD 2025-09-01
PublicationDate_xml – month: 09
  year: 2025
  text: 2025-09-01
  day: 01
PublicationDecade 2020
PublicationPlace Netherlands
PublicationPlace_xml – name: Netherlands
PublicationTitle International journal of cardiology congenital heart disease
PublicationTitleAlternate Int J Cardiol Congenit Heart Dis
PublicationYear 2025
Publisher Elsevier B.V
Elsevier
Publisher_xml – name: Elsevier B.V
– name: Elsevier
References Oliva, Giugno, Moroni, Sturla, Piazza, Saracino, Micheletti, d'Aiello, Reali, Chessa, Carminati (bib5) 2024 Apr; 103
Abaci, Unlu, Alsancak (bib1) 2013; 82
Mameli, Barcellona, Marongiu (bib9) 2009; 27
Aquino, Muniz, Laufer (bib3) 2022; 99
Krumsdorf, Ostermayer, Billinger (bib2) 2004; 43
Molander, Bower, Frisell (bib10) 2021; 80
Chung, Peng, Lin (bib6) 2014; 73
Ungprasert, Srivali, Spanuchart (bib7) 2014; 33
Sommer, Love, Paolillo (bib4) 2020; 95
Zacharski, Brown, Memoli (bib8) 1992; 63
Aquino (10.1016/j.ijcchd.2025.100600_bib3) 2022; 99
Sommer (10.1016/j.ijcchd.2025.100600_bib4) 2020; 95
Chung (10.1016/j.ijcchd.2025.100600_bib6) 2014; 73
Zacharski (10.1016/j.ijcchd.2025.100600_bib8) 1992; 63
Oliva (10.1016/j.ijcchd.2025.100600_bib5) 2024; 103
Abaci (10.1016/j.ijcchd.2025.100600_bib1) 2013; 82
Mameli (10.1016/j.ijcchd.2025.100600_bib9) 2009; 27
Krumsdorf (10.1016/j.ijcchd.2025.100600_bib2) 2004; 43
Ungprasert (10.1016/j.ijcchd.2025.100600_bib7) 2014; 33
Molander (10.1016/j.ijcchd.2025.100600_bib10) 2021; 80
References_xml – volume: 103
  start-page: 741
  year: 2024 Apr
  end-page: 750
  ident: bib5
  article-title: Right disc thrombosis of the new gore cardioform ASD occluder
  publication-title: Cathet Cardiovasc Interv
– volume: 63
  start-page: 155
  year: 1992
  end-page: 162
  ident: bib8
  article-title: Pathways of coagulation activation in situ in rheumatoid synovial tissue
  publication-title: Clin Immunol Immunopathol
– volume: 33
  start-page: 297
  year: 2014
  end-page: 304
  ident: bib7
  article-title: Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis
  publication-title: Clin Rheumatol
– volume: 80
  start-page: 169
  year: 2021
  end-page: 175
  ident: bib10
  article-title: Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
  publication-title: Ann Rheum Dis
– volume: 27
  start-page: 846
  year: 2009
  end-page: 855
  ident: bib9
  article-title: Rheumatoid arthritis and thrombosis
  publication-title: Clin Exp Rheumatol
– volume: 43
  start-page: 302
  year: 2004
  end-page: 309
  ident: bib2
  article-title: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients
  publication-title: J Am Coll Cardiol
– volume: 82
  start-page: 1123
  year: 2013
  end-page: 1138
  ident: bib1
  article-title: Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies
  publication-title: Cathet Cardiovasc Interv
– volume: 99
  start-page: 1161
  year: 2022
  end-page: 1164
  ident: bib3
  article-title: GORE Cardioform ASD device thrombus weeks after COVI-19 infection
  publication-title: Cathet Cardiovasc Interv
– volume: 95
  start-page: 1285
  year: 2020
  end-page: 1295
  ident: bib4
  article-title: ASSURED Investigators. ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect
  publication-title: Cathet Cardiovasc Interv
– volume: 73
  start-page: 1774
  year: 2014
  end-page: 1780
  ident: bib6
  article-title: Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study
  publication-title: Ann Rheum Dis
– volume: 33
  start-page: 297
  year: 2014
  ident: 10.1016/j.ijcchd.2025.100600_bib7
  article-title: Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis
  publication-title: Clin Rheumatol
  doi: 10.1007/s10067-014-2492-7
– volume: 27
  start-page: 846
  year: 2009
  ident: 10.1016/j.ijcchd.2025.100600_bib9
  article-title: Rheumatoid arthritis and thrombosis
  publication-title: Clin Exp Rheumatol
– volume: 73
  start-page: 1774
  year: 2014
  ident: 10.1016/j.ijcchd.2025.100600_bib6
  article-title: Rheumatoid arthritis increases the risk of deep vein thrombosis and pulmonary thromboembolism: a nationwide cohort study
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2013-203380
– volume: 103
  start-page: 741
  issue: 5
  year: 2024
  ident: 10.1016/j.ijcchd.2025.100600_bib5
  article-title: Right disc thrombosis of the new gore cardioform ASD occluder
  publication-title: Cathet Cardiovasc Interv
  doi: 10.1002/ccd.31002
– volume: 99
  start-page: 1161
  year: 2022
  ident: 10.1016/j.ijcchd.2025.100600_bib3
  article-title: GORE Cardioform ASD device thrombus weeks after COVI-19 infection
  publication-title: Cathet Cardiovasc Interv
  doi: 10.1002/ccd.30067
– volume: 63
  start-page: 155
  year: 1992
  ident: 10.1016/j.ijcchd.2025.100600_bib8
  article-title: Pathways of coagulation activation in situ in rheumatoid synovial tissue
  publication-title: Clin Immunol Immunopathol
  doi: 10.1016/0090-1229(92)90008-C
– volume: 80
  start-page: 169
  year: 2021
  ident: 10.1016/j.ijcchd.2025.100600_bib10
  article-title: Risk of venous thromboembolism in rheumatoid arthritis, and its association with disease activity: a nationwide cohort study from Sweden
  publication-title: Ann Rheum Dis
  doi: 10.1136/annrheumdis-2020-218419
– volume: 43
  start-page: 302
  year: 2004
  ident: 10.1016/j.ijcchd.2025.100600_bib2
  article-title: Incidence and clinical course of thrombus formation on atrial septal defect and patient foramen ovale closure devices in 1,000 consecutive patients
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2003.10.030
– volume: 82
  start-page: 1123
  year: 2013
  ident: 10.1016/j.ijcchd.2025.100600_bib1
  article-title: Short and long term complications of device closure of atrial septal defect and patent foramen ovale: meta-analysis of 28,142 patients from 203 studies
  publication-title: Cathet Cardiovasc Interv
  doi: 10.1002/ccd.24875
– volume: 95
  start-page: 1285
  year: 2020
  ident: 10.1016/j.ijcchd.2025.100600_bib4
  article-title: ASSURED Investigators. ASSURED clinical study: new GORE® CARDIOFORM ASD occluder for transcatheter closure of atrial septal defect
  publication-title: Cathet Cardiovasc Interv
  doi: 10.1002/ccd.28728
SSID ssj0002810051
Score 2.3021634
Snippet A 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum atrial...
AbstractA 67-year-old female patient with rheumatoid arthritis that was well suppressed by medications except for steroids had catheter closure of the secundum...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 100600
SubjectTerms Atrial septal defect
Cardiovascular
Case Report
Congenital heart disease
GORE cardioform ASD occluder
Rheumatoid arthritis
Thrombus formation
Title GORE® CARDIOFORM ASD occluder thrombus in a patient of rheumatoid arthritis occurred three days after deployment
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2666668525000369
https://www.clinicalkey.es/playcontent/1-s2.0-S2666668525000369
https://dx.doi.org/10.1016/j.ijcchd.2025.100600
https://www.ncbi.nlm.nih.gov/pubmed/40698378
https://www.proquest.com/docview/3232490058
https://pubmed.ncbi.nlm.nih.gov/PMC12281148
https://doaj.org/article/6ce5d5f99da748dbb5554169d66ea5d9
Volume 21
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQT1wQCArhURmp14h1Nnbs49IHBalUaovUm-XYY21WkMBmc-if6o_gl-FxkioLSO2he4o2mTzG48w3zsw3hOxnDDzyjKUgATBAQcpbOU8Laxzj1uYFx9rh06_i5Fv-5YpfTVp9YU5YTw_cK-6DsMAd90o5U-TSlSUPDpAJ5YQAw10s3Qs-bxJMreKSEUNzG2vlYkJXtbJ2ieSgGcfcAIFFbRNfFCn7t1zSv5Dz78zJiSs6fkqeDBiSLvp7f0YeQf2c_Pp0dn70-4YeLM4PP5-F2O6ULi4OaWPt987BmmI_hB9l19KqpoYOdKq08XS9hC7A1qZyNGhjGUmOUAyJmxyKAVBnrlsa24lTB9giGNcUX5DL46PLg5N06KeQWi7VJjXGOCUy73iIEjJrpc-FkRBCQGsVFtGWRWZyp1wO3pQ-ICcvGCtZ2PIyy-e7ZKduanhFaO7dTIIvmVQ2B-vlTGWFFzM1D8LGFglJR8Xqnz1rhh7TyVa6HwiNA6H7gUjIR9T-7bHIeR3_CJagB0vQd1lCQvg4dnosKw0vwnCi6o6LF_-Tg3aYza1mus30TF8EMBN-Er8EI4-PmkoOgKUHIve45vvRuHSYz_iRxtTQdK2eI8RV2O0xIS97Y7tVC1YpYwOAhMgtM9zS2_aeulpGznCWhSkRQt_XD6HpN-QxPkufaveW7GzWHbwL2GxT7sVpuBcXzf4A1AY6rQ
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=GORE%C2%AE+CARDIOFORM+ASD+occluder+thrombus+in+a+patient+of+rheumatoid+arthritis+occurred+three+days+after+deployment&rft.jtitle=International+journal+of+cardiology+congenital+heart+disease&rft.au=Nakagawa%2C+Naomi&rft.au=Shigemitsu%2C+Yusuke&rft.au=Okamoto%2C+Kengo&rft.date=2025-09-01&rft.pub=Elsevier&rft.eissn=2666-6685&rft.volume=21&rft_id=info:doi/10.1016%2Fj.ijcchd.2025.100600&rft.externalDocID=PMC12281148
thumbnail_m http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F26666685%2Fcov200h.gif